{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T17:50:54Z","timestamp":1784397054369,"version":"3.55.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated demyelinating disease of the peripheral nervous system (PNS). A small number of CIDP patients harbors autoantibodies against nodal\/paranodal proteins, such as neurofascin 155 (NF155), contactin 1, and contactin-associated protein 1. In most cases, the predominant immunoglobulin (IgG) subclass is IgG4. Node\/paranode antibody-positive CIDP demonstrates distinct features compared with antibody-negative CIDP, including a poor response to intravenous immunoglobulin. The neuropathology of biopsied sural nerve shows Schwann cell terminal loop detachment from axons without macrophage infiltration or inflammation. This is partly attributable to IgG4, which blocks protein\u2013protein interactions without inducing inflammation. Anti-NF155 antibody-positive (NF155<jats:sup>+<\/jats:sup>) CIDP is unique because of the high frequency of subclinical demyelinating lesions in the central nervous system (CNS). This is probably because NF155 coexists in the PNS and CNS. Such cases showing demyelinating lesions in both the CNS and PNS are now termed combined central and peripheral demyelination (CCPD). NF155<jats:sup>+<\/jats:sup> CIDP\/CCPD commonly presents hypertrophy of spinal nerve roots and cranial nerves, such as trigeminal and oculomotor nerves, and extremely high levels of cerebrospinal fluid (CSF) protein, which indicates nerve root inflammation. In the CSF, the CXCL8\/IL8, IL13, TNF\u03b1, CCL11\/eotaxin, CCL2\/MCP1, and IFN\u03b3 levels are significantly higher and the IL1\u03b2, IL1ra, and GCSF levels are significantly lower in NF155<jats:sup>+<\/jats:sup> CIDP than in non-inflammatory neurological diseases. Even compared with anti-NF155 antibody-negative (NF155<jats:sup>\u2212<\/jats:sup>) CIDP, the CXCL8\/IL8 and IL13 levels are significantly higher and the IL1\u03b2 and IL1ra levels are significantly lower than those in NF155<jats:sup>+<\/jats:sup> CIDP. Canonical discriminant analysis revealed NF155<jats:sup>+<\/jats:sup> and NF155<jats:sup>\u2212<\/jats:sup> CIDP to be separable with IL4, IL10, and IL13, the three most significant discriminators, all of which are required for IgG4 class switching. Therefore, upregulation of both Th2 and Th1 cytokines and downregulation of macrophage-related cytokines are characteristic of NF155<jats:sup>+<\/jats:sup> CIDP, which explains spinal root inflammation and the lack of macrophage infiltration in the sural nerves. All Japanese patients with NF155<jats:sup>+<\/jats:sup> CIDP\/CCPD have one of two specific human leukocyte antigen (HLA) haplotypes, which results in a significantly higher prevalence of <jats:italic>HLA-DRB1<\/jats:italic><jats:sup>*<\/jats:sup><jats:italic>15:01-DQB1<\/jats:italic><jats:sup>*<\/jats:sup><jats:italic>06:02<\/jats:italic> compared with healthy Japanese controls. This indicates an involvement of specific HLA class II molecules and relevant T cells in addition to IgG4 anti-NF155 antibodies in the mechanism underlying IgG4 NF155<jats:sup>+<\/jats:sup> CIDP\/CCPD.<\/jats:p>","DOI":"10.3389\/fneur.2021.665136","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T05:53:50Z","timestamp":1623304430000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":48,"title":["Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy\/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism"],"prefix":"10.3389","volume":"12","author":[{"given":"Jun-ichi","family":"Kira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1084\/jem.20071053","article-title":"Neurofascin as a novel target for autoantibody-mediated axonal injury","volume":"204","author":"Mathey","year":"2007","journal-title":"J Exp Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","article-title":"Neurofascin as a target for autoantibodies in peripheral neuropathies","volume":"79","author":"Ng","year":"2012","journal-title":"Neurology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1212\/WNL.0b013e3182a1aa9c","article-title":"Anti-neurofascin antibody in patients with combined central and peripheral demyelination","volume":"81","author":"Kawamura","year":"2013","journal-title":"Neurology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1212\/WNL.0000000000000205","article-title":"Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg","volume":"82","author":"Querol","year":"2014","journal-title":"Neurology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/acn3.248","article-title":"Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy","volume":"2","author":"Ogata","year":"2015","journal-title":"Ann Clin Transl Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1212\/WNL.0000000000002418","article-title":"Neurofascin 155 IgG4 in chronic inflammatory demyelinating polyneuropathy","volume":"86","author":"Devaux","year":"2016","journal-title":"Neurology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jneuroim.2016.10.013","article-title":"IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: clinical significance and diagnostic utility of a conventional assay","volume":"301","author":"Kadoya","year":"2016","journal-title":"J Neuroimmunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin 1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/jnnp-2014-309916","article-title":"Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin 1 autoantibodies","volume":"86","author":"Doppler","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/brain\/awv054","article-title":"Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia","volume":"138","author":"Miura","year":"2015","journal-title":"Brain."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1093\/brain\/aww189","article-title":"Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy","volume":"139","author":"Doppler","year":"2016","journal-title":"Brain."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/ene.12758","article-title":"The expanding field of IgG4-mediated neurological autoimmune disorders","volume":"22","author":"Huijbers","year":"2015","journal-title":"Eur J Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1002\/acn3.50931","article-title":"Intrathecal cytokine profile in neuropathy with anti-neurofascin 155 antibody","volume":"6","author":"Ogata","year":"2019","journal-title":"Ann Clin Transl Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1083\/jcb.150.3.657","article-title":"An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction","volume":"150","author":"Tait","year":"2000","journal-title":"J Cell Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.neuron.2005.10.019","article-title":"Neurofascins are required to establish axonal domains for saltatory conduction","volume":"48","author":"Sherman","year":"2005","journal-title":"Neuron."},{"key":"B16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jnnp-2014-309831","article-title":"A nationwide survey of combined central and peripheral demyelination in Japan","volume":"87","author":"Ogata","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B17","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.biocel.2012.01.012","article-title":"Neurofascin: a switch between neuronal plasticity and stability","volume":"44","author":"Kriebel","year":"2012","journal-title":"Int J Biochem Cell Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0896-6273(01)00306-3","article-title":"Organizing principles of the axoglial apparatus","volume":"30","author":"Pedraza","year":"2001","journal-title":"Neuron."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/jnr.22015","article-title":"Spatiotemporal ablation of myelinating glia-specific neurofascin (Nfasc NF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains","volume":"87","author":"Pillai","year":"2009","journal-title":"J Neurosci Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0896-6273(01)00296-3","article-title":"Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve","volume":"30","author":"Boyle","year":"2001","journal-title":"Neuron."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1083\/jcb.135.5.1355","article-title":"Molecular composition of the node of Ranvier: identification of ankyrin-binding cell adhesion molecules neurofascin (mucin+\/third FNIII domain-) and NrCAM at nodal axon segments","volume":"135","author":"Davis","year":"1996","journal-title":"J Cell Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1083\/jcb.200712154","article-title":"Glial and neuronal isoforms of neurofascin have distinct roles in the assembly of nodes of Ranvier in the central nervous system","volume":"181","author":"Zonta","year":"2008","journal-title":"J Cell Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5083","DOI":"10.1523\/JNEUROSCI.4662-13.2014","article-title":"Differential stability of PNS and CNS nodal complexes when neuronal neurofascin is lost","volume":"34","author":"Desmazieres","year":"2014","journal-title":"J Neurosci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e21392","DOI":"10.7554\/eLife.21392","article-title":"The paranodal cytoskeleton cluster Na+ channels at nodes of Ranvier","volume":"6","author":"Amor","year":"2017","journal-title":"eLife."},{"key":"B25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41583-020-00406-8","article-title":"Mechanisms of node of Ranvier assembly","volume":"22","author":"Rasband","year":"2021","journal-title":"Nat Rev Nerusci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jneuroim.2014.09.012","article-title":"Antibodies to neurofascin exacerbate adoptive transfer experimental autoimmune neuritis","volume":"277","author":"Yan","year":"2014","journal-title":"J Neuroimmunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"577074","DOI":"10.1016\/j.jneuroim.2019.577074","article-title":"Chronic inflammatory demyelinating polyneuropathy with anti-NF155 IgG4 in China","volume":"337","author":"Zhang","year":"2019","journal-title":"J Neuroimmunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1007\/s00415-020-10041-z","article-title":"Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera","volume":"267","author":"Delmont","year":"2020","journal-title":"J Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e639","DOI":"10.1212\/NXI.0000000000000639","article-title":"F. Antibodies to neurofascin, contactin 1, and contactin-associated protein 1 in CIDP","volume":"7","author":"Cortese","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e817","DOI":"10.1212\/NXI.0000000000000817","article-title":"Antiparanodal antibodies and IgG subclasses in acute autoimmune neuropathy","volume":"7","author":"Appeltshauser","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain-Barr\u00e9 syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J Peripher Nerv Syst."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1002\/acn3.51220","article-title":"Optic, trigeminal and facial neuropathy related to anti-neurofascin 155 antibody","volume":"7","author":"Ogata","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/(sici)1097-4598(199812)21:12<1673::aid-mus8>3.0.co;2-a","article-title":"Mandibular nerve involvement in diabetic polyneuropathy and chronic inflammatory demyelinating polyneuropathy","volume":"21","author":"Cruccu","year":"1998","journal-title":"Muscle Nerve."},{"key":"B34","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.1002\/mus.25731","article-title":"Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"57","author":"Wang","year":"2018","journal-title":"Muscle Nerve."},{"key":"B35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/mus.20679","article-title":"Neurophysiological evaluation of trigeminal and facial nerves in patients with chronic inflammatory demyelinating polyneuropathy","volume":"35","author":"Kokubun","year":"2007","journal-title":"Muscle Nerve."},{"key":"B36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrneurol.2014.260","article-title":"Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders","volume":"11","author":"Stathopoulos","year":"2015","journal-title":"Nat Rev Neurol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/S1388-2457(00)00478-8","article-title":"Visual evoked potentials study in chronic idiopathic inflammatory demyelinating polyneuropathy","volume":"111","author":"Stojkovic","year":"2000","journal-title":"Clin Neurophysiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1001\/archneur.1988.00520330104017","article-title":"Evoked potentials in chronic inflammatory demyelinating polyneuropathy","volume":"45","author":"Pakalnis","year":"1988","journal-title":"Arch Neurol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/ane.12226","article-title":"Optic and auditory pathway dysfunction in demyelinating neuropathies","volume":"130","author":"Knopp","year":"2014","journal-title":"Acta Neurol Scand."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1212\/NXI.0000000000000238","article-title":"Neurofascin 155 as a putative antigen in combined central and peripheral demyelination","volume":"3","author":"Cortese","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflammation."},{"key":"B41","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00330-016-4406-3","article-title":"Evaluation of chronic inflammatory demyelinating polyneuropathy: 3D nerve-sheath signal increased with inked rest-tissue rapid acquisition of relaxation enhancement imaging (3D SHINKEI)","volume":"27","author":"Hiwatashi","year":"2017","journal-title":"Eur Radiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1212\/WNL.0000000000003616","article-title":"Teaching NeuroImages: cranial nerve hypertrophy in IgG4 anti-neurofascin 155 antibody-positive polyneuropathy","volume":"88","author":"Franques","year":"2017","journal-title":"Neurology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/jnnp-2016-314895","article-title":"Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin 155 and anti-contactin 1 antibodies","volume":"88","author":"Koike","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B44","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/mus.25757","article-title":"Electron microscopic abnormality and therapeutic efficacy in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin 155 immunoglobulin G4 antibody","volume":"57","author":"Kuwahara","year":"2018","journal-title":"Muscle Nerve."},{"key":"B45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.nmd.2016.10.008","article-title":"Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies","volume":"27","author":"Vallat","year":"2017","journal-title":"Neuromusc Disord."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1212\/WNL.0000000000006625","article-title":"Ultrastructural mechanisms of macrophage-induced demyelination in CIDP","volume":"91","author":"Koike","year":"2018","journal-title":"Neurology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.24860","article-title":"Anti-LGI1 encephalitis is associated with unique HLA subtypes","volume":"81","author":"Kim","year":"2017","journal-title":"Ann Neurol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1212\/01.wnl.0000339103.08830.86","article-title":"HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5","volume":"72","author":"Bartoccioni","year":"2009","journal-title":"Neurology."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1212\/01.wnl.0000218159.79769.5c","article-title":"Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5","volume":"66","author":"Niks","year":"2006","journal-title":"Neurology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1681\/ASN.2016060644","article-title":"HLA-DRB1*15, 01 and HLA-DRB3*02, 02 in PLA2R-related membranous nephropathy","volume":"28","author":"Le","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1538-7836.2010.03772.x","article-title":"HLA-DRB1*11: A strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians","volume":"8","author":"Coppo","year":"2010","journal-title":"J Thromb Haemost."},{"key":"B52","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12974-017-0996-1","article-title":"Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15","volume":"14","author":"Martinez-Martinez","year":"2017","journal-title":"J Neuroinflammation."},{"key":"B53","doi-asserted-by":"publisher","first-page":"577139","DOI":"10.1016\/j.jneuroim.2019.577139","article-title":"Unique HLA haplotype associations in IgG4 anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy","volume":"339","author":"Ogata","year":"2020","journal-title":"J Neuroimmunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.humimm.2013.06.025","article-title":"Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry","volume":"74","author":"Gragert","year":"2013","journal-title":"Hum Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"D423","DOI":"10.1093\/nar\/gku1161","article-title":"The IPD and IMGT\/HLA database: allele variant databases","volume":"43","author":"Robinson","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1399-0039.1995.tb03125.x","article-title":"HLA class II region nucleotide sequences, 1995","volume":"46","author":"Marsh","year":"1995","journal-title":"Tissue Antigens."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1084\/jem.188.8.1511","article-title":"Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein","volume":"188","author":"Smith","year":"1998","journal-title":"J Exp Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1136\/jnnp-2017-316427","article-title":"Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial","volume":"88","author":"Kuwabara","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B59","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/jns.12302","article-title":"Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies","volume":"24","author":"Merkies","year":"2019","journal-title":"J Peripher Nerv Syst."},{"key":"B60","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2174\/157015909790031166","article-title":"Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies","volume":"7","author":"Jacob","year":"2009","journal-title":"Curr Neuropharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/jdv.12772","article-title":"Pemphigus. S2 Guideline for diagnosis and treatment\u2013guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)","volume":"29","author":"Hertl","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","journal-title":"Br J Haematol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2017.11.035","article-title":"Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"384","author":"Fujita","year":"2018","journal-title":"J Neurol Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1212\/NXI.0000000000000149","article-title":"Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins","volume":"2","author":"Querol","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B65","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/jns.12287","article-title":"Rituximab in chronic inflammatory demyelinating polyradiculoneuropathy with associated diseases","volume":"23","author":"Roux","year":"2018","journal-title":"J Peripher Nerv Syst."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e603","DOI":"10.1212\/NXI.0000000000000603","article-title":"Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy","volume":"6","author":"Stengel","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B67","doi-asserted-by":"publisher","first-page":"117098","DOI":"10.1016\/j.jns.2020.117098","article-title":"Refractory CIDP: clinical characteristics, antibodies and response to alternative treatment","volume":"418","author":"Godil","year":"2020","journal-title":"J Neurol Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1093\/brain\/aww062","article-title":"Contactin 1 IgG4 antibodies cause paranode dismantling and conduction defects","volume":"139","author":"Manso","year":"2016","journal-title":"Brain."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1172\/JCI124694","article-title":"Anti\u2013neurofascin 155 IgG4 antibodies prevent paranodal complex formation in vivo","volume":"129","author":"Manso","year":"2019","journal-title":"J Clin Invest"},{"key":"B70","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.msard.2017.03.007","article-title":"Cerebrospinal fluid and serum levels of interleukin-8 in patients with multiple sclerosis and its correlation with Q-albumin","volume":"14","author":"Matej\u010d\u00edkov\u00e1","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"B71","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/00004647-199703000-00005","article-title":"Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production","volume":"17","author":"Kossmann","year":"1997","journal-title":"J Cereb Blood Flow Metab."},{"key":"B72","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fneur.2017.00724","article-title":"Neurofascin (NF)155- and NF186-specific T cell response in a patient developing a central pontocerebellar demyelination after 10 years of CIDP","volume":"8","author":"Klehmet","year":"2017","journal-title":"Front Neuro"},{"key":"B73","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.cell.2013.04.007","article-title":"Single naive CD4+ T cells from a diverse repertoire produce different effector cell types during infection","volume":"153","author":"Tubo","year":"2013","journal-title":"Cell."},{"key":"B74","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.it.2014.09.008","article-title":"TCR signal quantity and quality in CD4+T cell differentiation","volume":"35","author":"Tubo","year":"2014","journal-title":"Trends Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e17117","DOI":"10.2196\/17117","article-title":"Efficacy and safety of rituximab in refractory CIDP with or without IgG4 autoantibodies (RECIPE): protocol for a double-blind, randomized, placebo-controlled clinical trial to the JMIR research protocols","volume":"9","author":"Shimizu","year":"2020","journal-title":"JMIR Res Protoc."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.665136\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T05:53:53Z","timestamp":1623304433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.665136\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":75,"alternative-id":["10.3389\/fneur.2021.665136"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.665136","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]},"article-number":"665136"}}